| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CRL - Creightons Plc | BUY | 1,035 @ USD 170.59 | USD 176,561 | The ETF bought 1035 new shares of CRL (Creightons Plc). The shares were bought for an average price of 170.59 compared to the previous average buy price of 176.546. This is -3.4% lower than average price of previous purchases of CRL. |
| INCY - Incyte Corporation | BUY | 2,435 @ USD 67.73 | USD 164,923 | The ETF bought 2435 new shares of INCY (Incyte Corporation). The shares were bought for an average price of 67.73 compared to the previous average buy price of 73.6385. This is -8.0% lower than average price of previous purchases of INCY. |
| ALGN - Align Technology Inc | BUY | 992 @ USD 164.57 | USD 163,253 | The ETF bought 992 new shares of ALGN (Align Technology Inc). The shares were bought for an average price of 164.57 compared to the previous average buy price of 210.621. This is -21.9% lower than average price of previous purchases of ALGN. |
| VTRS - Viatris Inc | BUY | 17,658 @ USD 9.24 | USD 163,160 | The ETF bought 17658 new shares of VTRS (Viatris Inc). The shares were bought for an average price of 9.24 compared to the previous average buy price of 11.6897. This is -21.0% lower than average price of previous purchases of VTRS. |
| RVTY - Revvity Inc. | BUY | 1,392 @ USD 111.52 | USD 155,236 | The ETF bought 1392 new shares of RVTY (Revvity Inc.). The shares were bought for an average price of 111.52 compared to the previous average buy price of 117.17. This is -4.8% lower than average price of previous purchases of RVTY. |
| HOLX - Hologic Inc | BUY | 2,466 @ USD 61.1 | USD 150,673 | The ETF bought 2466 new shares of HOLX (Hologic Inc). The shares were bought for an average price of 61.1 compared to the previous average buy price of 71.3728. This is -14.4% lower than average price of previous purchases of HOLX. |
| DGX - Quest Diagnostics Incorporated | BUY | 842 @ USD 166.42 | USD 140,126 | The ETF bought 842 new shares of DGX (Quest Diagnostics Incorporated). The shares were bought for an average price of 166.42 compared to the previous average buy price of 164.827. This is 1.0% higher than average price of previous purchases of DGX. |
| STE - STERIS plc | BUY | 573 @ USD 224.45 | USD 128,610 | The ETF bought 573 new shares of STE (STERIS plc). The shares were bought for an average price of 224.45 compared to the previous average buy price of 220.501. This is 1.8% higher than average price of previous purchases of STE. |
| RMD - ResMed Inc | BUY | 432 @ USD 220.22 | USD 95,135 | The ETF bought 432 new shares of RMD (ResMed Inc). The shares were bought for an average price of 220.22 compared to the previous average buy price of 240.994. This is -8.6% lower than average price of previous purchases of RMD. |
| CVS - CVS Health Corp | BUY | 1,207 @ USD 64.84 | USD 78,262 | The ETF bought 1207 new shares of CVS (CVS Health Corp). The shares were bought for an average price of 64.84 compared to the previous average buy price of 59.8465. This is 8.3% higher than average price of previous purchases of CVS. |
| GEHC - GE HealthCare Technologies Inc. | BUY | 929 @ USD 83.79 | USD 77,841 | The ETF bought 929 new shares of GEHC (GE HealthCare Technologies Inc.). The shares were bought for an average price of 83.79 compared to the previous average buy price of 88.572. This is -5.4% lower than average price of previous purchases of GEHC. |
| BDX - Becton Dickinson and Company | BUY | 183 @ USD 223.82 | USD 40,959 | The ETF bought 183 new shares of BDX (Becton Dickinson and Company). The shares were bought for an average price of 223.82 compared to the previous average buy price of 232.187. This is -3.6% lower than average price of previous purchases of BDX. |
| ELV - Elevance Health Inc | BUY | 44 @ USD 411.04 | USD 18,086 | The ETF bought 44 new shares of ELV (Elevance Health Inc). The shares were bought for an average price of 411.04 compared to the previous average buy price of 402.163. This is 2.2% higher than average price of previous purchases of ELV. |
| ELV - Elevance Health Inc | BUY | 44 @ USD 411.04 | USD 18,086 | The ETF bought 44 new shares of ELV (Elevance Health Inc). The shares were bought for an average price of 411.04 compared to the previous average buy price of 402.163. This is 2.2% higher than average price of previous purchases of ELV. |
| HCA - HCA Holdings Inc | BUY | 57 @ USD 312.87 | USD 17,834 | The ETF bought 57 new shares of HCA (HCA Holdings Inc). The shares were bought for an average price of 312.87 compared to the previous average buy price of 335.124. This is -6.6% lower than average price of previous purchases of HCA. |
| MCK - McKesson Corporation | SELL | -23 @ USD 640.66 | USD -14,735 | The ETF sold 23 shares of MCK on 2025-03-12. The shares were previously bought for an average price of USD 598.565. The McKesson Corporation shares were sold for 7.0% higher than average price of previous purchases. This sale made a profit of USD 968 The average price that the ETF previously sold MCK share for is USD so the ETF has sold 23 shares on 2025-03-12 at a higher price than the previous selling average. |
| TFX - Teleflex Incorporated | SELL | -143 @ 135.52 | -19,379 | The ETF sold 143 shares of TFX on 2025-03-12. The shares were previously bought for an average price of 186.315. The Teleflex Incorporated shares were sold for -27.3% lower than average price of previous purchases. This resulted in an overall loss of 7,264 The average price that the ETF previously sold TFX share for is so the ETF has sold 143 shares on 2025-03-12 at a higher price than the previous selling average. |
| DVA - DaVita HealthCare Partners Inc | SELL | -143 @ USD 142.63 | USD -20,396 | The ETF sold 143 shares of DVA on 2025-03-12. The shares were previously bought for an average price of USD 158.241. The DaVita HealthCare Partners Inc shares were sold for -9.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,232 The average price that the ETF previously sold DVA share for is USD so the ETF has sold 143 shares on 2025-03-12 at a higher price than the previous selling average. |
| HSIC - Henry Schein Inc | SELL | -387 @ USD 69.94 | USD -27,067 | The ETF sold 387 shares of HSIC on 2025-03-12. The shares were previously bought for an average price of USD 74.842. The Henry Schein Inc shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,897 The average price that the ETF previously sold HSIC share for is USD so the ETF has sold 387 shares on 2025-03-12 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -58 @ USD 495.42 | USD -28,734 | The ETF sold 58 shares of VRTX on 2025-03-12. The shares were previously bought for an average price of USD 470.767. The Vertex Pharmaceuticals Inc shares were sold for 5.2% higher than average price of previous purchases. This sale made a profit of USD 1,430 The average price that the ETF previously sold VRTX share for is USD so the ETF has sold 58 shares on 2025-03-12 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -178 @ USD 161.68 | USD -28,779 | The ETF sold 178 shares of ZTS on 2025-03-12. The shares were previously bought for an average price of USD 169.776. The Zoetis Inc shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,441 The average price that the ETF previously sold ZTS share for is USD so the ETF has sold 178 shares on 2025-03-12 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -42 @ USD 689.5 | USD -28,959 | The ETF sold 42 shares of REGN on 2025-03-12. The shares were previously bought for an average price of USD 744.325. The Regeneron Pharmaceuticals Inc shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,303 The average price that the ETF previously sold REGN share for is USD so the ETF has sold 42 shares on 2025-03-12 at a higher price than the previous selling average. |
| TECH - Bio-Techne Corp | SELL | -489 @ USD 60.235 | USD -29,455 | The ETF sold 489 shares of TECH on 2025-03-12. The shares were previously bought for an average price of USD 69.6777. The Bio-Techne Corp shares were sold for -13.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,617 The average price that the ETF previously sold TECH share for is USD so the ETF has sold 489 shares on 2025-03-12 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -177 @ USD 166.61 | USD -29,490 | The ETF sold 177 shares of UHS on 2025-03-12. The shares were previously bought for an average price of USD 193.004. The Universal Health Services Inc shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,672 The average price that the ETF previously sold UHS share for is USD so the ETF has sold 177 shares on 2025-03-12 at a higher price than the previous selling average. |
| SOLV - Solventum Corp. | SELL | -421 @ USD 74.01 | USD -31,158 | The ETF sold 421 shares of SOLV on 2025-03-12. The shares were previously bought for an average price of USD 74.6241. The Solventum Corp. shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 259 The average price that the ETF previously sold SOLV share for is USD so the ETF has sold 421 shares on 2025-03-12 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -1,031 @ USD 35.01 | USD -36,095 | The ETF sold 1031 shares of MRNA on 2025-03-12. The shares were previously bought for an average price of USD 38.4991. The Moderna Inc shares were sold for -9.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,597 The average price that the ETF previously sold MRNA share for is USD so the ETF has sold 1031 shares on 2025-03-12 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -611 @ USD 79.07 | USD -48,312 | The ETF sold 611 shares of COO on 2025-03-12. The shares were previously bought for an average price of USD 95.6596. The The Cooper Companies, Inc. Common Stock shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 10,136 The average price that the ETF previously sold COO share for is USD so the ETF has sold 611 shares on 2025-03-12 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -225 @ USD 224.23 | USD -50,452 | The ETF sold 225 shares of WST on 2025-03-12. The shares were previously bought for an average price of USD 277.822. The West Pharmaceutical Services Inc shares were sold for -19.3% lower than average price of previous purchases. This resulted in an overall loss of USD 12,058 The average price that the ETF previously sold WST share for is USD so the ETF has sold 225 shares on 2025-03-12 at a higher price than the previous selling average. |
| BAX - Baxter International Inc | SELL | -1,567 @ USD 34.41 | USD -53,920 | The ETF sold 1567 shares of BAX on 2025-03-12. The shares were previously bought for an average price of USD 33.4817. The Baxter International Inc shares were sold for 2.8% higher than average price of previous purchases. This sale made a profit of USD 1,455 The average price that the ETF previously sold BAX share for is USD so the ETF has sold 1567 shares on 2025-03-12 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -218 @ USD 248.38 | USD -54,147 | The ETF sold 218 shares of PODD on 2025-03-12. The shares were previously bought for an average price of USD 271.008. The Insulet Corporation shares were sold for -8.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,933 The average price that the ETF previously sold PODD share for is USD so the ETF has sold 218 shares on 2025-03-12 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -266 @ USD 204.96 | USD -54,519 | The ETF sold 266 shares of DHR on 2025-03-12. The shares were previously bought for an average price of USD 224.507. The Danaher Corporation shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 5,200 The average price that the ETF previously sold DHR share for is USD so the ETF has sold 266 shares on 2025-03-12 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -266 @ USD 204.96 | USD -54,519 | The ETF sold 266 shares of DHR on 2025-03-12. The shares were previously bought for an average price of USD 224.507. The Danaher Corporation shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 5,200 The average price that the ETF previously sold DHR share for is USD so the ETF has sold 266 shares on 2025-03-12 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -573 @ USD 96.42 | USD -55,249 | The ETF sold 573 shares of BSX on 2025-03-12. The shares were previously bought for an average price of USD 97.5426. The Boston Scientific Corporation shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 643 The average price that the ETF previously sold BSX share for is USD so the ETF has sold 573 shares on 2025-03-12 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -573 @ USD 96.42 | USD -55,249 | The ETF sold 573 shares of BSX on 2025-03-12. The shares were previously bought for an average price of USD 97.5426. The MULSTRXSSXIMETFP shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 643 The average price that the ETF previously sold BSX share for is USD so the ETF has sold 573 shares on 2025-03-12 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -177 @ USD 314.97 | USD -55,750 | The ETF sold 177 shares of MOH on 2025-03-12. The shares were previously bought for an average price of USD 304.163. The MOH shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 1,913 The average price that the ETF previously sold MOH share for is USD so the ETF has sold 177 shares on 2025-03-12 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -177 @ USD 314.97 | USD -55,750 | The ETF sold 177 shares of MOH on 2025-03-12. The shares were previously bought for an average price of USD 304.163. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 1,913 The average price that the ETF previously sold MOH share for is USD so the ETF has sold 177 shares on 2025-03-12 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -515 @ USD 113.99 | USD -58,705 | The ETF sold 515 shares of GILD on 2025-03-12. The shares were previously bought for an average price of USD 100.126. The Guild Esports Plc shares were sold for 13.8% higher than average price of previous purchases. This sale made a profit of USD 7,140 The average price that the ETF previously sold GILD share for is USD so the ETF has sold 515 shares on 2025-03-12 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -168 @ USD 363.84 | USD -61,125 | The ETF sold 168 shares of SYK on 2025-03-12. The shares were previously bought for an average price of USD 384.425. The Stryker Corporation shares were sold for -5.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,458 The average price that the ETF previously sold SYK share for is USD so the ETF has sold 168 shares on 2025-03-12 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -259 @ USD 236.83 | USD -61,339 | The ETF sold 259 shares of LH on 2025-03-12. The shares were previously bought for an average price of USD 244.328. The Laboratory Corporation of America Holdings shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,942 The average price that the ETF previously sold LH share for is USD so the ETF has sold 259 shares on 2025-03-12 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -124 @ USD 497.3 | USD -61,665 | The ETF sold 124 shares of ISRG on 2025-03-12. The shares were previously bought for an average price of USD 567.672. The Intuitive Surgical Inc shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 8,726 The average price that the ETF previously sold ISRG share for is USD so the ETF has sold 124 shares on 2025-03-12 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -448 @ USD 140.19 | USD -62,805 | The ETF sold 448 shares of BIIB on 2025-03-12. The shares were previously bought for an average price of USD 151.698. The Biogen Inc shares were sold for -7.6% lower than average price of previous purchases. This resulted in an overall loss of USD 5,156 The average price that the ETF previously sold BIIB share for is USD so the ETF has sold 448 shares on 2025-03-12 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -611 @ USD 104.03 | USD -63,562 | The ETF sold 611 shares of ZBH on 2025-03-12. The shares were previously bought for an average price of USD 106.764. The Zimmer Biomet Holdings Inc shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,670 The average price that the ETF previously sold ZBH share for is USD so the ETF has sold 611 shares on 2025-03-12 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -128 @ USD 512.65 | USD -65,619 | The ETF sold 128 shares of TMO on 2025-03-12. The shares were previously bought for an average price of USD 544.399. The Time Out Group plc shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,064 The average price that the ETF previously sold TMO share for is USD so the ETF has sold 128 shares on 2025-03-12 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -213 @ USD 312.5 | USD -66,563 | The ETF sold 213 shares of AMGN on 2025-03-12. The shares were previously bought for an average price of USD 301.35. The Amgen Inc shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 2,375 The average price that the ETF previously sold AMGN share for is USD so the ETF has sold 213 shares on 2025-03-12 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -184 @ USD 373.13 | USD -68,656 | The ETF sold 184 shares of WAT on 2025-03-12. The shares were previously bought for an average price of USD 377.65. The Waters Corporation shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 832 The average price that the ETF previously sold WAT share for is USD so the ETF has sold 184 shares on 2025-03-12 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -184 @ USD 373.13 | USD -68,656 | The ETF sold 184 shares of WAT on 2025-03-12. The shares were previously bought for an average price of USD 377.65. The MULETFWATIMETFP shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 832 The average price that the ETF previously sold WAT share for is USD so the ETF has sold 184 shares on 2025-03-12 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -232 @ USD 311.05 | USD -72,164 | The ETF sold 232 shares of CI on 2025-03-12. The shares were previously bought for an average price of USD 310.724. The Cigna Corp shares were sold for 0.1% higher than average price of previous purchases. This sale made a profit of USD 76 The average price that the ETF previously sold CI share for is USD so the ETF has sold 232 shares on 2025-03-12 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -2,838 @ USD 25.71 | USD -72,965 | The ETF sold 2838 shares of PFE on 2025-03-12. The shares were previously bought for an average price of USD 26.2737. The Pfizer Inc shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,600 The average price that the ETF previously sold PFE share for is USD so the ETF has sold 2838 shares on 2025-03-12 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -69 @ USD 1216.02 | USD -83,905 | The ETF sold 69 shares of MTD on 2025-03-12. The shares were previously bought for an average price of USD 1284.57. The Mettler-Toledo International Inc shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,730 The average price that the ETF previously sold MTD share for is USD so the ETF has sold 69 shares on 2025-03-12 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -69 @ USD 1216.02 | USD -83,905 | The ETF sold 69 shares of MTD on 2025-03-12. The shares were previously bought for an average price of USD 1284.57. The AMUNDI EUR GOV 710 shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,730 The average price that the ETF previously sold MTD share for is USD so the ETF has sold 69 shares on 2025-03-12 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,408 @ USD 59.81 | USD -84,212 | The ETF sold 1408 shares of BMY on 2025-03-12. The shares were previously bought for an average price of USD 57.2334. The Bloomsbury Publishing Plc shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of USD 3,628 The average price that the ETF previously sold BMY share for is USD so the ETF has sold 1408 shares on 2025-03-12 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -1,193 @ USD 70.76 | USD -84,417 | The ETF sold 1193 shares of DXCM on 2025-03-12. The shares were previously bought for an average price of USD 82.0139. The DexCom Inc shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 13,426 The average price that the ETF previously sold DXCM share for is USD so the ETF has sold 1193 shares on 2025-03-12 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -966 @ USD 93.35 | USD -90,176 | The ETF sold 966 shares of MRK on 2025-03-12. The shares were previously bought for an average price of USD 94.0733. The Marks Electrical Group PLC shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 699 The average price that the ETF previously sold MRK share for is USD so the ETF has sold 966 shares on 2025-03-12 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -966 @ USD 93.35 | USD -90,176 | The ETF sold 966 shares of MRK on 2025-03-12. The shares were previously bought for an average price of USD 94.0733. The Merck & Company Inc shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 699 The average price that the ETF previously sold MRK share for is USD so the ETF has sold 966 shares on 2025-03-12 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -1,547 @ USD 58.45 | USD -90,422 | The ETF sold 1547 shares of CNC on 2025-03-12. The shares were previously bought for an average price of USD 60.3083. The Concurrent Technologies Plc shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,875 The average price that the ETF previously sold CNC share for is USD so the ETF has sold 1547 shares on 2025-03-12 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -374 @ USD 249.11 | USD -93,167 | The ETF sold 374 shares of HUM on 2025-03-12. The shares were previously bought for an average price of USD 274.316. The Hummingbird Resources PLC shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 9,427 The average price that the ETF previously sold HUM share for is USD so the ETF has sold 374 shares on 2025-03-12 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -374 @ USD 249.11 | USD -93,167 | The ETF sold 374 shares of HUM on 2025-03-12. The shares were previously bought for an average price of USD 274.316. The Humana Inc shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 9,427 The average price that the ETF previously sold HUM share for is USD so the ETF has sold 374 shares on 2025-03-12 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -740 @ USD 126.83 | USD -93,854 | The ETF sold 740 shares of CAH on 2025-03-12. The shares were previously bought for an average price of USD 123.819. The Cardinal Health Inc shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 2,228 The average price that the ETF previously sold CAH share for is USD so the ETF has sold 740 shares on 2025-03-12 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -530 @ USD 185.42 | USD -98,273 | The ETF sold 530 shares of IQV on 2025-03-12. The shares were previously bought for an average price of USD 201.155. The IQVIA Holdings Inc shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 8,340 The average price that the ETF previously sold IQV share for is USD so the ETF has sold 530 shares on 2025-03-12 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -252 @ USD 412.4 | USD -103,925 | The ETF sold 252 shares of IDXX on 2025-03-12. The shares were previously bought for an average price of USD 444.383. The IDEXX Laboratories Inc shares were sold for -7.2% lower than average price of previous purchases. This resulted in an overall loss of USD 8,060 The average price that the ETF previously sold IDXX share for is USD so the ETF has sold 252 shares on 2025-03-12 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -882 @ USD 119.85 | USD -105,708 | The ETF sold 882 shares of A on 2025-03-12. The shares were previously bought for an average price of USD 136.809. The Agilent Technologies Inc shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 14,958 The average price that the ETF previously sold A share for is USD so the ETF has sold 882 shares on 2025-03-12 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,805 @ USD 68.51 | USD -123,661 | The ETF sold 1805 shares of EW on 2025-03-12. The shares were previously bought for an average price of USD 71.0221. The Edwards Lifesciences Corp shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 4,534 The average price that the ETF previously sold EW share for is USD so the ETF has sold 1805 shares on 2025-03-12 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -1,391 @ USD 91.51 | USD -127,290 | The ETF sold 1391 shares of MDT on 2025-03-12. The shares were previously bought for an average price of USD 88.9489. The Medtronic PLC shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of USD 3,562 The average price that the ETF previously sold MDT share for is USD so the ETF has sold 1391 shares on 2025-03-12 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -536 @ USD 254 | USD -136,144 | The ETF sold 536 shares of COR on 2025-03-12. The shares were previously bought for an average price of USD 245.82. The Cencora Inc. shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 4,384 The average price that the ETF previously sold COR share for is USD so the ETF has sold 536 shares on 2025-03-12 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -649 @ USD 212.06 | USD -137,627 | The ETF sold 649 shares of ABBV on 2025-03-12. The shares were previously bought for an average price of USD 187.474. The AbbVie Inc shares were sold for 13.1% higher than average price of previous purchases. This sale made a profit of USD 15,956 The average price that the ETF previously sold ABBV share for is USD so the ETF has sold 649 shares on 2025-03-12 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -880 @ USD 162.85 | USD -143,308 | The ETF sold 880 shares of JNJ on 2025-03-12. The shares were previously bought for an average price of USD 157.042. The Johnson & Johnson shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 5,111 The average price that the ETF previously sold JNJ share for is USD so the ETF has sold 880 shares on 2025-03-12 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -1,215 @ USD 130.28 | USD -158,290 | The ETF sold 1215 shares of ABT on 2025-03-12. The shares were previously bought for an average price of USD 125.311. The Abbott Laboratories shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of USD 6,037 The average price that the ETF previously sold ABT share for is USD so the ETF has sold 1215 shares on 2025-03-12 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -403 @ USD 481.11 | USD -193,887 | The ETF sold 403 shares of UNH on 2025-03-12. The shares were previously bought for an average price of USD 541.992. The UnitedHealth Group Incorporated shares were sold for -11.2% lower than average price of previous purchases. This resulted in an overall loss of USD 24,535 The average price that the ETF previously sold UNH share for is USD so the ETF has sold 403 shares on 2025-03-12 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -289 @ USD 821.86 | USD -237,518 | The ETF sold 289 shares of LLY on 2025-03-12. The shares were previously bought for an average price of USD 843.079. The Eli Lilly and Company shares were sold for -2.5% lower than average price of previous purchases. This resulted in an overall loss of USD 6,132 The average price that the ETF previously sold LLY share for is USD so the ETF has sold 289 shares on 2025-03-12 at a higher price than the previous selling average. |